Additionally, ABT-737 in combination with the BRAF inhibitor PLX4720 showed augmentation of apoptosis in BRAF mutant melanoma cell lines that was BIM dependent and mediated through an enhancement of the BIM:MCL-1 interaction [40]. The gene discussed is MCL1; the disease is melanoma.